Company logo

PDCO - Patterson Companies, Inc.

NASDAQ -> Healthcare -> Medical Distribution
Saint Paul, United States
Type: Equity

PDCO price evolution
PDCO
(in millions $) 30 Jul 2024 27 Feb 2024 28 Nov 2023 30 Oct 2023
Current assets
Cash $114.46 $124 $113.89
Short term investments
Net receivables $547.29 $484.53 $490.43 $408.93
Inventory $782.9 $902.73 $858.03 $912.67
Total current assets $1778.76 $1832.56 $1790.68 $1772.14
Long term investments $166.32 $164.46 $162.53
Property, plant & equipment $351.38 $334.52 $320.51 $320.57
Goodwill & intangible assets $349.59 $359.59 $368.35
Total noncurrent assets $1117.97 $1107.39 $1099.01
Total investments $166.32 $164.46 $162.53
Total assets $2896.73 $2939.95 $2889.69 $2883.63
Current liabilities
Accounts payable $745.38 $683.3 $688.69 $717.43
Deferred revenue
Short long term debt $341.56 $366.26 $236.13
Total current liabilities $1332.55 $1283.71 $1148.54 $1087.75
Long term debt $328.91 $448.22 $449.97 $450.6
Total noncurrent liabilities $562.45 $684.07 $686.06
Total debt $762.94 $894.98 $760.5
Total liabilities $1895.59 $1968.47 $1835.39 $1773.29
Shareholders' equity
Retained earnings $831.48 $802.88 $902.83 $948.73
Other shareholder equity -$89.92 -$86.16 -$98.96 -$81.63
Total shareholder equity $1001.14 $971.48 $1054.3
(in millions $) 31 Dec 2024 31 Dec 2023 31 Dec 2022 31 Dec 2021
Current assets
Cash $114.46 $159.67 $142.01 $143.24
Short term investments
Net receivables $677.16 $599.1 $585.97 $673.21
Inventory $782.9 $795.07 $785.6 $736.78
Total current assets $1778.76 $1783.14 $1679.02 $1615.93
Long term investments $166.32 $160.02 $139.18
Property, plant & equipment $351.38 $305.24 $283.86 $296.65
Goodwill & intangible assets $349.59 $388.29 $393.24 $419.58
Total noncurrent assets $1117.97 $1096.01 $1062.61 $1135.58
Total investments $166.32 $160.02 $139.18
Total assets $2896.73 $2879.15 $2741.63 $2751.51
Current liabilities
Accounts payable $745.38 $724.99 $681.32 $609.26
Deferred revenue
Short long term debt $341.56 $109.39 $58.35 $186
Total current liabilities $1332.55 $1085.33 $1015.67 $1089.67
Long term debt $421.38 $518.61 $531.89 $535.86
Total noncurrent liabilities $562.45 $675.28 $683.33 $697.17
Total debt $762.94 $628 $590.23 $721.87
Total liabilities $1895 $1760.61 $1698.99 $1786.84
Shareholders' equity
Retained earnings $831.48 $972.13 $921.7 $855.74
Other shareholder equity -$89.92 -$89.26 -$81.52 -$62.59
Total shareholder equity $1001.14 $1117.54 $1041.68 $963.22
(in millions $) 1 May 2025 30 Jul 2024 27 Feb 2024 28 Nov 2023
Revenue
Total revenue $1616.1 $1652.77
Cost of revenue
Gross Profit $351.01 $339.03
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $280.99 $282.12
Operating income
Income from continuing operations
EBIT
Income tax expense $14.35 $13.5
Interest expense -$11.72 -$10.64
Net income
Net income $47.7 $39.96
Income (for common shares)
(in millions $) 31 Dec 2024 31 Dec 2023 31 Dec 2022 31 Dec 2021
Revenue
Total revenue $6568.27 $6471.47 $6499.4 $5912.07
Cost of revenue $5188.03 $5098.53 $5210.32 $4708.94
Gross Profit $1380.24 $1372.94 $1289.09 $1203.13
Operating activities
Research & development
Selling, general & administrative $1127.32 $1096.97 $1132.09 $992.52
Total operating expenses $1127.32 $1096.97 $1132.09 $992.52
Operating income $252.92 $275.97 $157 $210.61
Income from continuing operations
EBIT $288.38 $304.76 $288.04 $225.09
Income tax expense $57.53 $63.56 $64.54 $44.82
Interest expense $44.91 $33.64 $20.29 $24.28
Net income
Net income $185.93 $207.56 $203.21 $155.98
Income (for common shares) $185.93 $207.56 $203.21 $155.98
(in millions $) 27 May 2024 27 Feb 2024 28 Nov 2023 29 Aug 2023
Net income
Operating activities
Depreciation
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations
Investing activities
Capital expenditures
Investments
Total cash flows from investing $959.54 $718.01 $454.86 $223.82
Financing activities
Dividends paid -$98.33 -$75.02 -$50.3 -$25.43
Sale and purchase of stock
Net borrowings
Total cash flows from financing -$215.91 -$34.09 -$13.16 -$23.12
Effect of exchange rate $0.53 $0.25 -$2.17 $1.57
Change in cash and equivalents -$45.21 -$35.67 -$45.79 -$51.1
(in millions $) 31 Dec 2024 31 Dec 2023 31 Dec 2022 31 Dec 2021
Net income $185.93 $207.56 $203.21 $155.98
Operating activities
Depreciation $88.16 $83.7 $81.99 $78.9
Business acquisitions & disposals $1027.17 $965.63 $1193.7 $833.96
Stock-based compensation $17.87 $15.54 $23.8 $30.49
Total cash flows from operations -$789.38 -$754.85 -$980.99 -$730.52
Investing activities
Capital expenditures -$67.63 -$64.22 -$38.31 -$25.79
Investments -$15 $75.94
Total cash flows from investing $959.54 $901.57 $1239.03 $810.66
Financing activities
Dividends paid -$98.33 -$101.35 -$101.11 -$75.18
Sale and purchase of stock -$229.51 -$55.49 -$35
Net borrowings $105 $14.5 -$124.75 $53
Total cash flows from financing -$215.91 -$126.48 -$253.23 -$22.64
Effect of exchange rate $0.53 -$2.58 -$6.03 $7.8
Change in cash and equivalents -$45.21 $17.66 -$1.23 $65.3
Fundamentals
Market cap $1.86B
Enterprise value N/A
Shares outstanding 89.70M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 1.89
Net debt/EBITDA N/A
Current ratio 1.33
Quick ratio 0.75